Dr. Martens plc (DOCS.L)
| Previous close | 74.05 |
| Open | 74.25 |
| Bid | 73.00 x N/A |
| Ask | 73.70 x N/A |
| Day's range | 71.20 - 74.90 |
| 52-week range | 62.00 - 174.70 |
| Volume | |
| Avg. volume | 1,883,025 |
| Market cap | 708.905M |
| Beta (5Y monthly) | -0.03 |
| PE ratio (TTM) | 7.37 |
| EPS (TTM) | 0.10 |
| Earnings date | 30 May 2024 |
| Forward dividend & yield | 0.06 (7.89%) |
| Ex-dividend date | 04 Jan 2024 |
| 1y target est | 85.16 |
FortuneGen Z favorite Dr. Martens is struggling as its CEO steps down—and it might be because their shoes last too long
Famously made to last, the durability that led to its popularity may be the very thing keeping it from astronomic growth.
Associated Press FinanceDr. Martens shares plunge to record low after weak US revenue outlook
Chunky bootmaker Dr. Martens is warning of a tough year ahead. Shares in Dr. Martens PLC, known as Doc Martens, plunged Tuesday after the iconic brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year. Dr. Martens also announced a leadership shakeup.
- Yahoo Finance Video
Dr. Martens stock plunges on 2025 warning, CEO departure
Shares of Dr. Martens (DOCS.L, DOCMF) are plunging after the boot maker warned its fiscal 2025 results will be hit by a double-digit decline in US wholesale revenue. The company also announced CEO Kenny Wilson will be stepping down at the end of the year. He will be replaced by Chief Brand Officer Ije Nwokorie. In the video above, Yahoo Finance's Seana Smith and Brad Smith discuss the announcements. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.
